ArticleArthritis research & therapy2009

RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.

Marina Stolina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.